Skip to content
Home » Valentine's Day » Local clinical trial for COVID-19 vaccine put on hold after AstraZeneca IDs issue in patient

Local clinical trial for COVID-19 vaccine put on hold after AstraZeneca IDs issue in patient

The clinical trial for a Coronavirus vaccine, which was taking place locally, has been put on hold.

It was taking place at the University of Rochester Medical Center, and involved a vaccine produced by AstraZeneca. The company voluntarily paused the Phase 3 clinical trial of the vaccine due to a potentially unexplained illness in a single research participant in the U.K.


As of Thursday none of the local volunteers have experienced any unexpected or severe reactions.

The research and trial will continue after a review is concluded. The 16 people in the Rochester area who have enrolled in the study since last week were contacted directly and informed of the incident.

Finger Lakes Partners (Billboard)